Regulatory/Legislative News

Visioneering Technologies Inc. announced that its NaturalVue daily disposable hydrophilic multifocal contact lens has been issued 510(k) clearance, according to a press release from the company.

The Refractive Surgery Alliance has formally demanded that the U.S. Centers for Disease Control and Prevention retract a November report that linked close to 1 million office visits each year to poor contact lens care, which it believes creates a false understanding of the risks of contact lenses.

The Optometry Board of Australia announced that it “will modify its guidelines on glaucoma diagnosis and management to make sure there are clear referral pathways to support patient safety and well-being.”

The American Board of Optometry's next board certification exam period is January 2015, the organization announced in a press release.  

Alimera Sciences announced that marketing authorization has been granted to Iluvien in the Netherlands.

The U.S. Food and Drug Administration has granted priority review for Eylea injection for the treatment of diabetic retinopathy in patients with diabetic macular edema, according to a Regeneron press release.

Alimera Sciences announced that marketing authorization has been granted to Iluvien in Ireland.

DENVER – Three presenters here at the American Academy of Optometry plenary session discussed the dangers of recreational use of cannabinoids and the potential benefits of medicinal use.

The Belgian Federal Agency for Medicines and Health Products has granted marketing approval for Iluvien to treat impaired vision associated with chronic diabetic macular edema, according to a press release from Alimera Sciences.

All five Primary Care Optometry News bloggers posted new entries within the past week. Topics cover age-related macular degeneration, health care reform, technology, social media and nutrition.